Trial intelligence / Profile preview

Vitamin D for Insulin Resistance and Inflammation

NCT01354964Phase 2Completed

Sponsor
Albert Einstein College of Medicine
Start
Mar 2009
Primary completion
Jun 2015
Modality
Orthosteric Ligands, Metabolically Activated Prodrugs
Countries
1
01

Overview

A Phase 2 trial of vitamin d in insulin resistance (IR), Vitamin D deficiency (VDD), sponsored by Albert Einstein College of Medicine. Started Mar 2009; status: completed.

02

Drugs

vitamin d
03

Conditions

insulin resistance (IR)Vitamin D deficiency (VDD)

Beyond the preview

Go deeper on NCT01354964.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01354964.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call